Table 1: Prognostic factors for secondary cytoreductive surgery in recurrent ovarian cancer (univariate analyses for variables at recurrence).

Characteristic Median survival Onda, et al. [15] Median survival Eisenkop, et al. [16] Median survival Zang, et al. [18]
No. of patients 44 87 117
DFI (months)
3-12 18
13-23 26
≥ 24 40
< 12 23
≥ 12 47
6-12 25
13-36 44.4
> 36 56.8
Largest recurrence
≤ 10 cm 37.3
> 10 cm 35.6
< 6 cm 40 NA
≥ 6 cm 14
No. of recurrent tumours
Solitary 64 NA NS
Multiple 27
Liver metastasis
Absent 33 NA NA
Present 20
Cytoreductive outcome
Visibly disease free 55 44.4
Not visibly disease free 22 19.3
0 cm _b
≤ 1 cm 26
> 1 cm 14.5
Ascite
No NA 35.9 25.5
Yes 35.6 17.5
ECOG performance status
0 NS NS 40.5
1 24.5
2 15.0

DFI: Disease free interval; ECOG: Eastern cooperative oncology group; NA: Not analysed, NS: Not significant, _b: The median survival was not reached.